A new analysis found Radicava ORS (edaravone) slows functional decline and helps adults with amyotrophic lateral sclerosis ...

When columnist Dagmar Munn's special footwear began to wear out, she went shoe shopping — which required a certain amount of resilience.

A repurposed veterinary medication, NUZ-001, helped ALS patients live longer and slowed disease progression in a long-term study.

This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope ...

Can AI joke about ALS? Columnist Dagmar Munn finds that her chosen artificial intelligence app lacks her own sense of humor.

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS ...

Columnist Dagmar Munn describe how posture exercise is helping her eliminate her tendency to slouch, part of a weakening alignment.

While some of her caregiver responsibilities were more arduous than others, all brought a deep sense of loss, columnist ...